Tumor Clinical Trials in Tianjin, Tianjin Municipality
57 recruitingTianjin, Tianjin Municipality, China
Showing 1–20 of 57 trials
Recruiting
Phase 1
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
Breast CancerAdvanced Solid Tumor
BeOne Medicines86 enrolled23 locationsNCT07222267
Recruiting
Phase 3
An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.
Advanced Gastroenteropancreatic Neuroendocrine Tumor
Jiangsu HengRui Medicine Co., Ltd.220 enrolled1 locationNCT05884255
Recruiting
Phase 1
GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors
Solid Tumors, Adult
Grit Biotechnology31 enrolled5 locationsNCT05430373
Recruiting
Phase 1Phase 2
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
Hepatocellular CarcinomaSolid TumorsNon-small Cell Lung Cancer+1 more
3D Medicines (Sichuan) Co., Ltd.170 enrolled23 locationsNCT05024214
Recruiting
Phase 2
A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.
Pancreatic CancerSolid TumorKRAS P.G12C
Allist Pharmaceuticals, Inc.88 enrolled31 locationsNCT06008288
Recruiting
Phase 1
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Gastric CancerEsophageal AdenocarcinomaMetastatic Cancer+5 more
I-Mab Biopharma US Limited330 enrolled21 locationsNCT04900818
Recruiting
Phase 1Phase 2
Evaluate the Safety and Clinical Activity of HH2853
Advanced Solid TumorPeripheral T Cell LymphomaFL Lymphoma+1 more
Haihe Biopharma Co., Ltd.254 enrolled25 locationsNCT04390737
Recruiting
Phase 1Phase 2
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
HER2-positive Advanced Solid Tumor
DualityBio Inc.796 enrolled102 locationsNCT05150691
Recruiting
Phase 1Phase 2
A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration
Advanced Solid Tumor
Jacobio Pharmaceuticals Co., Ltd.334 enrolled32 locationsNCT06959615
Recruiting
Phase 1Phase 2
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
Ovarian CarcinomaNSCLCSCLC+5 more
Jacobio Pharmaceuticals Co., Ltd.152 enrolled1 locationNCT04686682
Recruiting
Phase 1Phase 2
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Advanced Solid Tumors
DualityBio Inc.862 enrolled107 locationsNCT05914116
Recruiting
Phase 1
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor
Gastrointestinal Tumor
Sichuan Baili Pharmaceutical Co., Ltd.96 enrolled6 locationsNCT05262491
Recruiting
Phase 1Phase 2
A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
Breast CancerAdvanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.414 enrolled20 locationsNCT07169994
Recruiting
Phase 1
A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas
Advanced Solid TumorAdvanced Lymphoma
CStone Pharmaceuticals480 enrolled38 locationsNCT05279300
Recruiting
Phase 2
Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer
Lung CancersRadiation Treatment for Tumors
Tianjin Medical University Cancer Institute and Hospital84 enrolled1 locationNCT06775678
Recruiting
Phase 1
APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors
Solid TumorNeuroblastoma
Ascentage Pharma Group Inc.100 enrolled3 locationsNCT05701306
Recruiting
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
TumorPositron Emission TomographyGLP1-R-related Disease+1 more
Tianjin Medical University500 enrolled1 locationNCT06725693
Recruiting
Phase 1
A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma
Advanced Solid TumorNSCLCLymphoma+1 more
Betta Pharmaceuticals Co., Ltd.110 enrolled4 locationsNCT05341557
Recruiting
Not Applicable
The Effect of Serum Ferritin in irAE
Acute LeukemiaMalignant Solid TumorsImmune-related Adverse Event+1 more
Tianjin Medical University Cancer Institute and Hospital1,500 enrolled1 locationNCT06702566
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients
Advanced Solid TumorAdvanced CancerLung Cancer, Nonsmall Cell
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.280 enrolled41 locationsNCT04237805